A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.
about
Lipid pathway alterations in Parkinson's disease primary visual cortexCholine Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled TrialMass spectrometry methodology in lipid analysis.Novel strategy for typing Mycoplasma pneumoniae isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry coupled with ClinProTools.Lipid mapping of colonic mucosa by cluster TOF-SIMS imaging and multivariate analysis in cftr knockout mice.Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.Cystic fibrosis bronchial epithelial cells are lipointoxicated by membrane palmitate accumulation.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.The emerging role of plasma lipidomics in cardiovascular drug discovery.Profiling eicosanoids and phospholipids using LC-MS/MS: principles and recent applications.Role of fatty acid-based functional lipidomics in the development of molecular diagnostic tools.Redox balance in cystic fibrosis.Biomarkers for cystic fibrosis drug development.Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.Lessons learned from metabolomics in cystic fibrosis.Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Quantification of plasma phospholipids by ultra performance liquid chromatography tandem mass spectrometry.
P2860
Q28386548-DED23F28-546E-47C0-8A8F-01C02213B764Q30278529-34173B4E-73B8-44E9-81FD-441C3C005545Q33907807-8DD5FB8D-0A0B-44E4-820F-03D32E876743Q34058770-80690BA6-82A4-4E98-8267-BC4DBDA08B6CQ34116335-C2145278-03B9-46BA-B485-B24CF15FF6ABQ34776256-790873D9-B840-492F-9973-6A8633DC91D7Q35106583-9875FC88-65AE-4A86-A7FE-EAD95503DA7DQ36112019-1FA59D9C-0287-4352-9734-02779A4E2D5FQ37999089-A931DC9E-92A7-4F08-B357-15E6154674DBQ38021711-CD271D1A-D927-49CF-80FD-4B3221DDE9AAQ38059900-D381D2B3-3FA2-4D76-928D-C909E61ED067Q38198442-CCF21870-EA26-49AF-9D89-76E18BB55E8CQ38755600-7FD0DE9B-75BC-4517-B8A2-0E6C13B0A8A8Q38839819-A59F7513-3EF4-47B0-94EB-A46FB3C2C760Q40920707-4EA7BE61-FEF0-4E28-B7A9-30DF3EC17698Q41517954-FAC277DB-1DE3-4EAC-B8F1-3D8C0471DF8FQ46246621-BD57FD89-D815-4781-8C81-48144447EC1BQ47831284-DE337E2E-BE79-42B8-B945-1FD4A9DE2D24Q51371679-329BDC20-0E33-41E8-A510-F446870B5453
P2860
A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@ast
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@en
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@nl
type
label
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@ast
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@en
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@nl
prefLabel
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@ast
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@en
A novel lipidomic strategy rev ...... y in cystic fibrosis patients.
@nl
P2093
P2860
P50
P1433
P1476
A novel lipidomic strategy rev ...... ty in cystic fibrosis patients
@en
P2093
Aleksander Edelman
Anna Nowakowska
Daniele Piomelli
Ida Chiara Guerrera
Isabelle Sermet-Gaudelus
Jean-Philippe Jais
Julien Colas
Martin Schuerenberg
P2860
P356
10.1371/JOURNAL.PONE.0007735
P407
P577
2009-11-06T00:00:00Z